SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success ...
The collaboration aims to increase accessibility for providers and patients across the U.S. and select global markets....
AI-driven care diagnostic imaging and care coordination to streamline physician workflows for timely and efficient patient care delivery ...
Asia will continue to be a large and rapidly growing market for diabetes care technologies. To be competitive and successful in the aggressive market with numerous large and startup companies, players will need large funds, a broad portfolio with desirable differentiators and a strong distribution network. Low-cost products, subscription-based solutions, reimbursement policies and training of patients and physicians will be required to promote the adoption among low income and middle-income regi...
Gamma Tech will distribute Pearl’s flagship AI solution, Second Opinion®, to the ANZ dental markets...
Measuring urine volume based on the difference in body weight before and after urination, eliminating the need for urine collection...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive agreement to acquire Telavant Holdings, Inc. (Telavant), a Roivant company, owned by Roivant Sciences Ltd. and Pfizer Inc....
First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins...
This is the second genomics facility to be operated by Redcliffe Labs in India...
GE HealthCare a collaboration with Novo Nordisk to further advance the clinical and product development of peripheral focused ultrasound (PFUS). This is a novel technology that has potential to specifically regulate metabolic function in the body using ultrasound that may support the treatment of chronic diseases such as type 2 diabetes and obesity....
